DISTINCTIVE FEATURES OF REHABILITATION FOR PATIENTS WITH ISCHEMIC STROKE FOLLOWING COVID-19
Keywords:
rehabilitation, post-COVID patients, ischemic strokeAbstract
According to expert estimates from the World Health Organization (WHO), stroke is the second leading cause of death worldwide. In 2019, the mortality rate from stroke exceeded 6.2 million people, or 127 per 100,000 people annually.
These data are relative, as not all cases of morbidity are recorded. The incidence of stroke varies significantly across different regions - from 5-8 to 1000 per 1 million population annually. The incidence of stroke varies significantly across different regions - from 5-8 to 1000 per capita per year.
References
Voronina TA Novie napravleniya poiska nootropicnix preparatov (problemnaya article). Vestnik RAMN.2000; (1):16-21
Voronina TA Mexidol: spectrum of pharmacological effects. Journal of Neurology and Psychiatry im. SSKorsakova. 2012;112 (12):86-90
Mikhailenko, AA Klinicheskiy praktikum po neurologni., Izdatelstvo: SPb: Foliant, 480 pages; 2001 ISBN: 5-93929-018-3
Skoromes AN Topicheskaya diagnosis zabolevaniy nervous system: management for doctors / AA Skoromes, AP Skoromes, TA Skoromes. - 8-ye izd., pererab. i grain - St. Petersburg: Polytechnic, 2012.
Bashkatova V, Narkevich V, Vitskova G, Vanin A. The effects of anticonvulsant and antioxidant drugs nitric oxide level and lipid peroxidation in the rat menthylenetetrazole-induced epileptiform model seizures. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(3):487-492. DOI:10.1016/S0278-5846 (03) 00037-X
Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses - a statement of the Coronavirus Study Group. bioRxiv 2020 937862v1 (Accessed on February 12, 2020).
Lu R, Zhao X, Li J, et al. Genomic characterization and 2019 novel coronavirus epidemiology: implications for virus origins and receptor binding. Lancet 2020; 395:565